Jianke Group Recognized Again as a Top Family-Favored Online Pharmacy Platform for 2019–2020
On September 16, 2020, the award ceremony for the “2019–2020 China Household Essential Medicines” series of brand activities was held in Guangzhou. The event was jointly hosted by Family Doctor Online, Ele.me Pharmaceutical Health, and New Generation Market Monitoring Agency, with Chuanmai Culture as co-organizer and Pharmaceutical Economic News as special media supporter. At the ceremony, three prestigious lists were officially unveiled: “Top Brands Listed in the 2019–2020 China Household Essential Medicines,” “2019–2020 China Pharmaceutical Enterprise Golden Cane Honor Roll,” and “2019–2020 China Preferred Household Online Pharmacy Platforms.” Jianke Group, a well-known domestic online smart healthcare service platform, was once again listed among the winners of the “China Preferred Household Online Pharmacy Platform” award.
Pictured is Ou Yubo, Senior Vice President of Jianke Group (third from right), accepting the award on stage.
At the awards ceremony, the unveiling of the three major lists was the highlight. According to the organizing committee, the “2019–2020 China Household Essential Medicines Listed Brands” is a curated selection of domestically outstanding household essential medicines from the past year; the “2019–2020 China Pharmaceutical Enterprises Golden Cane Honor Roll” recognizes pharmaceutical companies that demonstrated stable performance, outstanding marketing effectiveness, and proactive innovation over the previous year; and the “2019–2020 China Preferred Household Online Pharmacy Platforms” showcases online medication purchasing platforms with reliable domestic channels, user-friendly interfaces, and large user bases.
A total of 324 pharmaceutical products were registered for this event, yielding 10,357 valid consumer survey responses and 6,089,865 online votes. By integrating data from brand research, market surveys, sales figures from the “Ele.me” platform, and public voting, the final rankings featured 82 pharmaceutical products, 22 companies, and 11 medication purchasing platforms. Following the sequential announcement of the lists, more than 100 representatives from pharmaceutical companies took the stage in batches to receive their awards.
Pictured: Ou Yubo, Senior Vice President of Jianke Group (second from left), accepting the award on stage.
Among them, Jianke Group was listed on the “2019–2020 China’s Preferred Online Pharmacy Platform for Households” ranking, thanks to its outstanding technological innovation and operational integration capabilities. This marks the second consecutive year that Jianke Group has been featured on this prestigious list.
Jianke Group has recently achieved significant recognition within the industry, being selected for the Top 100 List of Comprehensive Strength of Chain Pharmacies in China. Furthermore, it was honored as an “E-commerce Operation Listed Enterprise” in the “2019–2020 Comprehensive Competitiveness Ranking of Chinese Pharmaceutical Retail Enterprises” at the CIP Gold Awards, often referred to as the “Oscars” of China’s pharmaceutical retail industry.
This also demonstrates that Jianke Group has gained further recognition within the industry. Amid the impact of the COVID-19 pandemic, the role of internet healthcare as a supplement to traditional medical services has become increasingly prominent, with a growing number of users embracing digital health solutions. According to the latest “Research Report on China’s Mobile Healthcare Market in the First Half of 2020” recently released by Bida Consulting, the number of mobile healthcare users in China reached 590 million in the first half of 2020, representing a 12.38% increase compared to 2019.
Notably, in the distribution of monthly active users for major medical service apps in China during the first half of 2020, Jianke Online Pharmacy, under the Jianke Group, ranked first. During the epidemic prevention period, its advantages of “convenient purchasing without the need to go out” made online medication purchases a new choice for consumers.
Data and industry awards also highlight Jianke Group’s outstanding performance on mobile platforms, further solidifying its leading position in the industry and demonstrating that Jianke Group is winning increasing recognition and favor from users through ever-improving service experiences in the internet healthcare sector.
Catalyzed by the pandemic, internet healthcare has witnessed a surge in user traffic. Many regions have gradually begun to incorporate “Internet + Medical Services” into medical insurance coverage, and the realization of online medical insurance payments will complete the final loop in the internet healthcare ecosystem.
Xie Fangmin, CEO of Jianke Group, stated that Jianke leverages internet technology to connect and integrate the entire industry chain, merging medical resources from various stakeholders to achieve comprehensive coverage of online pharmacies, internet hospitals, online consultations, and chronic disease management. This truly shifts medical services from hospitals to patients’ homes, enabling individuals to access products and chronic disease management services that span the entire life cycle and cover all healthcare scenarios without leaving home, thereby bringing high-quality medical resources into the households of countless people.
Going forward, Jianke will continue to strengthen the close integration of medical care and pharmaceuticals, consolidate more high-quality medical resources to advance the development of its H2H smart healthcare model, and develop more innovative technologies to enhance medical efficiency and improve drug accessibility.